HASCO Medical, Inc. Announces Acquisition Strategy
MOBILE, Ala., July 21 HASCO Medical, Inc. (OTC Bulletin Board: HASC), www.mysouthernmed.com, a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, today announced the Company will begin expansion throughout the continental United States. The Company has identified several acquisition targets that meet the criteria of building the next generation of Healthcare footprint in the US.
Hal Compton, Jr., Chief Executive Officer of HASCO Medical Inc., stated, "Our number one priority is caring for people. All too often patients are dealing with illness, not addressing how to pay. We make it easy and affordable for our patients to receive the health coverage they need and the products that make life enjoyable. This is the mantra we are going to carry with us state by state until HASCO Medical is a household name."
The model is relatively simple: Identify mom and pop healthcare facilities throughout the country and buy them with stock and cash. As compared to the competition, the HASCO strategy is to provide a profitable exit strategy for owners looking to retire or sell and keep them involved as an owner in the company with a stock incentive. If you are a managed health care provider and are looking to sell or require additional financing to help your business, please make HASCO Medical your first call.
About HASCO Medical, Inc.
HASCO Medical, Inc., is a managed healthcare provider of a broad range of home healthcare services that serve patients in Alabama, Florida, and Mississippi. The Company has two major service lines: home respiratory equipment and durable/ home medical equipment. The Company's objective is to be a leading provider of home health care products and services in the continental United States.
This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases you can identify those so-called "forward looking statements" by words such as "may," "will," "should," "expects," "plans," "targets," "believes," "anticipates," "estimates," "predicts," "potential," or "continue" or the negative of those words and other comparable words. These forward looking statements are subject to risks and uncertainties, product tests, commercialization risks, availability of financing and results of financing efforts that could cause actual results to differ materially from historical results or those anticipated. Further information regarding these and other risks is described from time to time in the Company's filings with the SEC, which are available on its website at: http://www.sec.gov. We assume no obligation to update or alter our forward-looking statements made in this release or in any periodic report filed by us under the Securities Exchange Act of 1934 or any other document, whether as a result of new information, future events or otherwise, except as otherwise required by applicable federal securities laws.
SOURCE HASCO Medical, Inc.
You May Also Like